Author

Razavi H

December 11, 2021
Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting
Summary In 2016, Asia and Pacific countries endorsed action plans for reaching viral hepatitis elimination targets set in the Global Health Sector Strategy (GHSS) for Viral Hepatitis 2016-2021. We examine the region’s progress by modelling disease burden and constructing the cascade of care. Between 2015 and 2020, chronic HBV prevalence declined from 4.69% to 4.30%, […]

Read More
December 1, 2021
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Summary Background & aims Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet largely underappreciated liver condition which is closely associated with obesity and metabolic disease. Despite affecting an estimated 1 in 4 adults globally, NAFLD is largely absent on national and global health agendas. Methods We collected data from 102 countries, accounting for […]

Read More
November 27, 2021
HCV disease burden and population segments in Switzerland
Summary Background Switzerland has made strides towards hepatitis C virus elimination, but as of 2019, elimination was not guaranteed. However, political interest in viral hepatitis has been increasing. We sought to develop a better understanding of Switzerland’s progress towards HCV elimination and the profile of remaining HCV-RNA-positive patients. Methods A previously described Markov model was […]

Read More
August 30, 2021
Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies
Summary Background & aims The aim of this study was to quantify the global epidemiology of primary sclerosing cholangitis (PSC), alongside the incidence of liver transplantation, cancer, and death, through robust systematic review of population-based data. Methods We searched MEDLINE and EMBASE up to and including June 30, 2020 to identify population-based studies reporting the […]

Read More
July 13, 2021
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world
Summary Background Vaccination is one of the most effective public health interventions. We investigate the impact of vaccination activities for Haemophilus influenzae type b, hepatitis B, human papillomavirus, Japanese encephalitis, measles, Neisseria meningitidis serogroup A, rotavirus, rubella, Streptococcus pneumoniae, and yellow fever over the years 2000-2030 across 112 countries. Methods Twenty-one mathematical models estimated disease burden using standardised demographic and […]

Read More
May 29, 2021
Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
Summary Background & Aims In 2014, the burden of hepatitis C virus (HCV) in Sweden was evaluated, to establish a baseline and inform public health interventions. Considering the changing landscape of HCV treatment, prevention, and care, and in light of the COVID-19 pandemic, this analysis seeks to evaluate Sweden’s progress towards the World Health Organization […]

Read More
January 30, 2021
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
Summary Background The past two decades have seen expansion of childhood vaccination programmes in low-income and middle-income countries (LMICs). We quantify the health impact of these programmes by estimating the deaths and disability-adjusted life-years (DALYs) averted by vaccination against ten pathogens in 98 LMICs between 2000 and 2030. Methods 16 independent research groups provided model-based […]

Read More
January 19, 2021
Progress towards hepatitis C virus elimination in high-income countries: An updated analysis
Summary Background & aims Elimination of HCV by 2030, as defined by the World Health Organization (WHO), is attainable with the availability of highly efficacious therapies. This study reports progress made in the timing of HCV elimination in 45 high-income countries between 2017 and 2019. Methods Disease progression models of HCV infection for each country […]

Read More
December 1, 2020
The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries
Summary No abstract available. Countries/Territories: Low-income countries, Middle-income countries

Read More
September 26, 2020
A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia
Summary Background No virologic cure exists for hepatitis B virus (HBV) infection, and existing therapies are designed to control viral replication. We aimed to estimate the national prevalence of HBsAg in 2017 and study the impact of an enhanced diagnosis rate and universal treatment administration on HBV-related outcomes in Saudi Arabia. Materials and methods A […]

Read More

Author

Razavi H

Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

HCV disease burden and population segments in Switzerland

Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies

Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

Progress towards hepatitis C virus elimination in high-income countries: An updated analysis

The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries

A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia

Useful Links, CDAF

Useful Links, Polaris

Latest News